Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus

16 Jul 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Influenza Virus Research Studies
Share to Respiratory viral infections research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 39013430
DOI: 10.1038/s41591-024-03189-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virusPMID 39013430Read ↗

Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protectionSemantic proximity Read ↗

A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A VirusSemantic proximity Read ↗

A clade 2.3.4.4b H5N1 virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteinsSemantic proximity Read ↗

Influenza B: Prospects for the Development of Cross-Protective VaccinesSemantic proximity Read ↗

Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of MiceSemantic proximity Read ↗

Antibody germline characterization of cross-neutralizing human IgGs against 4 serotypes of dengue virusSemantic proximity Read ↗

Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferretsSemantic proximity Read ↗

Consensus H3N2 HA immunogens incorporating key antigenic mutations elicit broad-spectrum neutralizing responses.Semantic proximity Read ↗

Assessment of cross-reactive neutralizing antibodies induction against H5N1 clade 2.3.4.4b by prior seasonal influenza immunization in retail workersSemantic proximity Read ↗

Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boostSemantic proximity Read ↗

A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinSemantic proximity Read ↗

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza virusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.